Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples